• Living with IPF and Navigating the Changes
  • Researchers Discover New Targets to Inhibit Pulmonary Fibrosis
  • Let’s Treat Ourselves with Kindness
  • Pharmaxis’ LOXL2 Inhibitor Shows Positive Results in Phase 1 Trial in Healthy Volunteers
  • Forming Meaningful Friendships with a Chronic Illness
  • Analysis of Phase 3 Trial Data Shows Benefits of Esbriet for More Advanced IPF Patients
  • Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments
  • Taking Time to Express Gratitude
  • Ofev Prevented Lung Cancer Progression in IPF Patient, Case Report Shows
  • X-Rx Completes Early Studies on X-165 for Potential IPF Treatment, Supporting IND Application
  • A Gratitude Miniseries: September 2018
  • Ofev, Sildenafil Combo Shows No Added Benefit in IPF Patients with Poor Lung Function, Study Shows